A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas
Clinical trial NCT01132911 · COMPLETED
Trial details
- NCT number
- NCT01132911
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-10
- Primary completion
- 2011-04-13
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.